81 VRE

Sunday, April 3, 2011: 1:00 PM-2:15 PM
Trinity Ballroom (Hilton Anatole)
Type: Abstracts
606
Case Series Of Daptomycin Non-Susceptible Enterococcus Infections In A Tertiary Center
Theodoros Kelesidis, MD, Ronald Reagan UCLA Medical Center; Daniel Uslan, MD, Ronald Reagan UCLA Medical Center; David Pegues, MD, Ronald Reagan UCLA Medical Center
607
Combination of High Dose Daptomycin with Tigecycline as Treatment of Persistent Vancomycin Resistant Enterococcus Bacteremia
Theodoros Kelesidis, MD, David Geffen School of Medicine, UCLA; Romney Humphries, PhD, David Geffen School of Medicine, UCLA
608
Local Spread of Tn1546 among Three Species of Vancomycin Resistant Enterococci in an Intensive Care Unit
Milica Jovanovic, MD, Clinic for Infectious and Tropical Deseases; Tanja Tosic, MD, Clinic for Infectious and Tropical Deseases; Branka Stosovic, MD, Clinic for Infectious and Tropical Deseases; Zorica Dakic, DVM, Clinic for Infectious and Tropical Deseases; Janetta Top, University Medical Center Utrecht; NIkola Indjic, MD, Institute for preventive medicine; Gordana Lazarevic, MD, University Children's Clinic; Sladjana Pavic, MD, General Hospital Uzice; Rob Willems, PhD, University Medical Center Utrecht
609
Risk Factors for Colonization or Infection with Vancomycin-Resistant Enterococcus on an Inpatient Hematology/Oncology Ward
Nicholas B. Haun, BS, University of Wisconsin School of Medicine and Public Health; John Marx, MPH, UW Health; Rosa Mak, MS, UW Health; Nasia Safdar, MD, University of Wisconsin School of Medicine and Public Health
610
Recurrent Outbreak of Vancomycin resistant Enterococcus faecium (VRE) in Hematology/ Oncology Patients at a Comprehensive Cancer Center
Stacy L. Martin, RN, BSN, CIC, H. Lee Moffitt Cancer Center and Research Institute; Kay Sams, RN, BSN, CIC, H. Lee Moffitt Cancer Center and Research Institute; John Greene, MD, FACP, H. Lee Moffitt Cancer Center and Research Institute; Ana Paula Velez, MD, H. Lee Moffitt Cancer Center and Research Institute; Rod Quilitz, PharmD, BCOP, H. Lee Moffitt Cancer Center and Research Institute
611
Co-colonization of Vancomycin-Resistant Enterococcus faecalis and Methicillin-Resistant Staphylococcus aureus (MRSA) at Detroit Medical Center
Kayoko Hayakawa, MD, PhD, Detroit Medical Center, Wayne State University; Dror Marchaim, MD, Detroit Medical Center, Wayne State University; Jason M. Pogue, PharmD, Detroit Medical Center, Wayne State University; Paul R. Lephart, PhD, Detroit Medical Center, Wayne State University; Bharath Sunkara, MD, Detroit Medical Center, Wayne State University; Harikrishna Kotra, MBBS, Detroit Medical Center, Wayne State University; Asma Hasan, BS, Detroit Medical Center, Wayne State University; Judy Moshos, MT, Detroit Medical Center, Wayne State University; Maryann Shango, BS, Detroit Medical Center, Wayne State University; Yashwanth Yerramalla, MBBS, Detroit Medical Center, Wayne State University; Sarwan Kumar, MD, Detroit Medical Center, Wayne State University; Vicki Collins, MD, Detroit Medical Center, Wayne State University; Kimberley Ku, BS, Detroit Medical Center, Wayne State University; Palaniappan Manickam, MD, MPH, Detroit Medical Center, Wayne State University; Sagar Mallikethi Lepakshi Reddy, MBBS, Detroit Medical Center, Wayne State University; Kavyashri Kodlipet Jagadeesh, MBBS, Detroit Medical Center, Wayne State University; Verma Sourabh, MBBS, Detroit Medical Center, Wayne State University; Adedayo Morenike Omotola, MBBS, Detroit Medical Center, Wayne State University; Dhivya Sundaramurthy, MBBS, Detroit Medical Center, Wayne State University; Suchitha Bheemreddy, MD, Detroit Medical Center, Wayne State University; Jessie Swan, BS, Detroit Medical Center, Wayne State University; Lakisha Burton Willis, MBA, Detroit Medical Center, Wayne State University; Satyam Patel, MBBS, Detroit Medical Center, Wayne State University; Rupali Krishana, BA, Detroit Medical Center, Wayne State University; Maninderpal Dhillon, BS, Detroit Medical Center, Wayne State University; Nimrit Sohal, Detroit Medical Center, Wayne State University; Hardik Doshi, MBBS, Detroit Medical Center, Wayne State University; Neelu Chugh, MBBS, Detroit Medical Center, Wayne State University; Miriam Levine, BA, Detroit Medical Center, Wayne State University; Victoria Yee, BS, MS, Detroit Medical Center, Wayne State University; Farah Ahmad, MD, Detroit Medical Center, Wayne State University; Umme Suhrawardy, MBBS, Detroit Medical Center, Wayne State University; Chika Okoronkwo, MD, Detroit Medical Center, Wayne State University; Teena Chopra, MD, Detroit Medical Center, Wayne State University; Sorabh Dhar, MD, Detroit Medical Center, Wayne State University; Keith S. Kaye, MD, MPH, Detroit Medical Center, Wayne State University
612
Epidemology and Risk Factors for Bacteremia due to Vancomycin-resistant Enterococcus (VRE): E. faecalis compared to E. faecium
Kayoko Hayakawa, MD, PhD, Detroit Medical Center, Wayne State University; Dror Marchaim, MD, Detroit Medical Center, Wayne State University; Jason M. Pogue, Pharm, D, Detroit Medical Center, Wayne State University; Paul R. Lephart, PhD, Detroit Medical Center, Wayne State University; Bharath Sunkara, MD, Detroit Medical Center, Wayne State University; Judy Moshos, MT, Detroit Medical Center, Wayne State University; Harikrishna Kotra, MBBS, Detroit Medical Center, Wayne State University; Asma Hasan, BS, Detroit Medical Center, Wayne State University; Maryann Shango, BS, Detroit Medical Center, Wayne State University; Yashwanth Yerramalla, MBBS, Detroit Medical Center, Wayne State University; Sarwan Kumar, MD, Detroit Medical Center, Wayne State University; Vicki Collins, MD, Detroit Medical Center, Wayne State University; Kimberley Ku, BS, Detroit Medical Center, Wayne State University; Palaniappan Manickam, MD, MPH, Detroit Medical Center, Wayne State University; Sagar Mallikethi Lepakshi Reddy, MBBS, Detroit Medical Center, Wayne State University; Kavyashri Kodlipet Jagadeesh, MBBS, Detroit Medical Center, Wayne State University; Verma Sourabh, MBBS, Detroit Medical Center, Wayne State University; Adedayo Morenike Omotola, MBBS, Detroit Medical Center, Wayne State University; Dhivya Sundaramurthy, MBBS, Detroit Medical Center, Wayne State University; Suchitha Bheemreddy, MD, Detroit Medical Center, Wayne State University; Jessie Swan, BS, Detroit Medical Center, Wayne State University; Lakisha Burton Willis, MBA, Detroit Medical Center, Wayne State University; Satyam Patel, MBBS, Detroit Medical Center, Wayne State University; Rupali Krishana, Detroit Medical Center, Wayne State University; Maninderpal Dhillon, BS, Detroit Medical Center, Wayne State University; Nimrit Sohal, Detroit Medical Center, Wayne State University; Hardik Doshi, MBBS, Detroit Medical Center, Wayne State University; Neelu Chugh, MBBS, Detroit Medical Center, Wayne State University; Miriam Levine, BA, Detroit Medical Center, Wayne State University; Victoria Yee, BS, MS, Detroit Medical Center, Wayne State University; Farah Ahmad, MD, Detroit Medical Center, Wayne State University; Umme Suhrawardy, MBBS, Detroit Medical Center, Wayne State University; Chika Okoronkwo, MD, Detroit Medical Center, Wayne State University; Teena Chopra, MD, Detroit Medical Center, Wayne State University; Sorabh Dhar, MD, Detroit Medical Center, Wayne State University; Keith .S Kaye, MD, MPH, Detroit Medical Center, Wayne State University
613
Emergence of Resistance during Therapy with Daptomycin for Infections due to Vancomycin-Resistant Enterococci (VRE)
Luke F. Chen, MBBS, MPH, Duke University Medical Center; Deverick J. Anderson, MD, MPH, Duke University Medical Center; Eileen K. Maziarz, MD, Duke University Medical Center; Becky A. Miller, MD, Duke University Medical Center; Rebekah W. Moehring, MD, Duke University Medical Center; L. Barth Reller, MD, Duke University Medical Center; Daniel J. Sexton, MD, Duke University Medical Center; Christopher D. Pfeiffer, MD, Duke University Medical Center
614
Characterizing and Containing VRE Acquisition Among Stem Cell Transplant and Medical Oncology Inpatients
Robin T. Odom, MS, National Institutes of Health Clinical Center; Ninet Sinaii, PhD, National Institutes of Health Clinical Center; Philip L. Mussenden Jr., BS, Howard University College of Medicine; Frida Stock, BS, National Institutes of Health Clinical Center; MaryAnn Bordner, MS, National Institutes of Health Clinical Center; Angela V. Michelin, MPH, National Institutes of Health Clinical Center; Daniel P. Fedorko, PhD, National Institutes of Health Clinical Center; Patrick R. Murray, PhD, National Institutes of Health Clinical Center; David K. Henderson, MD, National Institutes of Health Clinical Center; Tara N. Palmore, MD, National Institutes of Health Clinical Center
615
Controlling Transmission of Vancomycin-resistant Enterococcus faecium Across Multiple Hospital Units
Tobias Pusch, MD, Parkland Health and Hospital System, University of Texas Southwestern Medical Center, Medicine - Division of Infectious Diseases; Dale Kemp, LVN, Department of Infection Prevention, Parkland Health and Hospital System; Sylvia Trevino, MT, CIC, Department of Infection Prevention, Parkland Health and Hospital System; Thomas Button, RN, CIC, Department of Infection Prevention, Parkland Health and Hospital System; Pablo Sanchez, MD, University of Texas Southwestern Medical Center, Department of Pediatrics; Rita M. Gander, PhD, Parkland Health and Hospital System, University of Texas Southwestern Medical Center, Department of Pathology; Pranavi Sreeramoju, MD, MPH, Parkland Health and Hospital System, University of Texas Southwestern Medical Center, Medicine - Division of Infectious Diseases